Health Care & Life Sciences » Pharmaceuticals | Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
54,912.00
69,323.00
67,359.00
74,271.00
72,384.00
93,323
Total Accounts Receivable
24,585.00
22,852.00
33,233.00
26,777.00
35,996.00
52,163
Inventories
69,916.00
82,332.00
70,665.00
79,754.00
63,609.00
69,322
Other Current Assets
23,558.00
23,489.00
4,677.00
3,294.00
15,789.00
5,534
Total Current Assets
172,971.00
197,996.00
175,934.00
184,096.00
187,778.00
220,342
Net Property, Plant & Equipment
116,619.00
138,289.00
142,161.00
152,944.00
185,339.00
210,418
Intangible Assets
40,163.00
42,565.00
39,901.00
50,307.00
45,140.00
42,267
Other Assets
2,877.00
3,588.00
4,696.00
9,390.00
8,663.00
9,918
Total Assets
338,748.00
389,370.00
390,136.00
427,738.00
454,665.00
513,563
ST Debt & Current Portion LT Debt
22,104.00
7,594.00
10,934.00
5,366.00
6,312.00
Accounts Payable
20,380.00
10,161.00
13,872.00
19,932.00
16,629.00
Income Tax Payable
2,847.00
4,316.00
3,076.00
7,705.00
3,325.00
Other Current Liabilities
20,071.00
40,524.00
32,073.00
27,614.00
40,926.00
Total Current Liabilities
65,402.00
62,595.00
59,955.00
60,617.00
67,192.00
Long-Term Debt
10,069.00
36,106.00
30,165.00
32,356.00
40,844.00
Provision for Risks & Charges
-
-
1,260.00
845.00
879.00
Deferred Taxes
1,036.00
1,094.00
27,444.00
29,546.00
26,384.00
Other Liabilities
4,578.00
2,971.00
3,246.00
3,210.00
7,060.00
Total Liabilities
87,203.00
107,510.00
94,626.00
98,483.00
117,336.00
Common Equity (Total)
251,545.00
281,860.00
295,510.00
329,255.00
337,329.00
Total Shareholders' Equity
251,545.00
281,860.00
295,510.00
329,255.00
337,329.00
Total Equity
251,545.00
281,860.00
295,510.00
329,255.00
337,329.00
Liabilities & Shareholders' Equity
338,748.00
389,370.00
390,136.00
427,738.00
454,665.00

About Amphastar Pharmaceuticals

View Profile
Address
11570 6th Street
Rancho Cucamonga California 91730
United States
Employees -
Website http://www.amphastar.com
Updated 07/08/2019
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.